Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer

By sjmartinez • June 12, 2023

Ziyeh S, Wong L, Basho RK. Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer. Curr Oncol Rep. 2023 Jul;25(7):689-698. doi: 10.1007/s11912-023-01393-6. Epub 2023 Apr 1. PMID: 37004700.

Tags: AKT inhibition, CDK4/6 inhibition, CERANs, Endocrine therapy, Fellow, General Internal Medicine, Hematology/Oncology, HER2 negative breast cancer, Hormone receptor-positive breast cancer, Olive View DoM, PI3K inhibition, PIK3CA mutation, PROTACs, Publications, SARMs, SERCAs, SERDs, SERMs

Evolving growth hormone deficiency: proof of concept

Chimatapu SN, Sethuram S, Samuels JG, Klomhaus A, Mintz C, Savage MO, Rapaport R. Evolving growth hormone deficiency: proof of concept. Front Endocrinol (Lausanne). 2024[...]

Investigating MRI-Associated Biological Aspects of Racial Disparities in Prostate Cancer for African American and White Men

Zabihollahy F, Miao Q, Naim S, Sonni I, Vangala S, Kim H, Hsu W, Sisk A, Reiter R, Raman SS, Sung K. Investigating MRI-Associated Biological[...]

A structured approach to modifying an implementation package while scaling up a complex evidence-based practice

Cordasco KM, Gabrielian SE, Barnard J, Harris T, Finley EP. A structured approach to modifying an implementation package while scaling up a complex evidence-based practice.[...]